Atlas Trials

Phase 1 Study of Quizartinib

Clinical trial NCT02675478 · COMPLETED

Trial details

NCT number
NCT02675478
Sponsor
Daiichi Sankyo Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed AMLRefractory AML
Start date
2016-02-01
Primary completion
2018-11-13
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.